Statistics for Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
Total visits
| views | |
|---|---|
| Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies | 136 |
Total visits per month
| views | |
|---|---|
| January 2025 | 2 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Isorhamnetin_RPahceco_ADEQ.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 85 |
| Portugal | 16 |
| China | 12 |
| Australia | 11 |
| India | 4 |
| Tunisia | 3 |
| Russia | 2 |
| Chile | 1 |
| Germany | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Carcavelos | 1 |